Ausdal Financial Partners’s Cano Health, Inc. CANO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-140
Closed -$3.55K 471
2023
Q3
$3.55K Sell
140
-10
-7% -$822 ﹤0.01% 433
2023
Q2
$20.9K Sell
150
-250
-63% -$32.1K ﹤0.01% 428
2023
Q1
$36.4K Sell
400
-50
-11% -$6.79K 0.01% 440
2022
Q4
$61.6K Buy
450
+310
+221% +$105K 0.01% 434
2022
Q3
$121K Sell
140
-80
-36% -$50.1K 0.02% 420
2022
Q2
$96K Sell
220
-10
-4% -$5.21K 0.01% 432
2022
Q1
$146K Buy
230
+80
+53% +$50.4K 0.02% 462
2021
Q4
$134K Buy
+150
New +$158K 0.02% 465

Other funds holding CANO

Ausdal Financial Partners's CANO Position: Q4 2023 in Review

Ausdal Financial Partners sold out of Cano Health, Inc. (CANO) in Q4 2023, closing a stake of 140 shares — an estimated $3.55K sold.

Ausdal Financial Partners first reported a position in CANO in Q4 2021 and held it in 8 quarters. The position peaked at $146K in Q1 2022. 50 funds tracked by Wall St. Rank hold CANO as of Q4 2023.

  • Ausdal Financial Partners reported no remaining Cano Health, Inc. position as of Q4 2023 after selling out during the quarter.
  • Ausdal Financial Partners sold 140 Cano Health, Inc. shares in Q4 2023, an estimated $3.55K.
  • Ausdal Financial Partners first reported a position in Cano Health, Inc. in Q4 2021 and held it in 8 quarters.
  • Ausdal Financial Partners's Cano Health, Inc. position peaked at $146K in Q1 2022.
  • 50 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2023.

Based on Ausdal Financial Partners's 13F filing for Q4 2023, filed 11 Jan 2024.